32. Kutup A., Link B.C., Schurr P.G. et al. Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer // Endoscopy. 2007. Vol. 39, N 8. P. 715–719.
33. DaVee T., Ajani J.A., Lee J.H. Is endoscopic ultrasound examination necessary in the management of esophageal cancer? // World J. Gastroenterol. 2017. Vol. 23, N 5. P. 751–762.
34. Kaushik N., Khalid A., Brody D. et al. Endoscopic ultrasound compared with laparoscopy for staging esophageal cancer // Ann. Thorac. Surg. 2007. Vol. 83. P. 2000–2002.
35. Sgourakis G., Gockel I., Lyros O. et al. Detection of lymph node metastases in esophageal cancer // Expert Rev. Anticancer Ther. 2011. Vol. 11. P. 601–612.
36. Портной Л.М., Казанцева И.А., Мазурин В.С. и др. О роли традиционной рентгенологии в дифференциальной диагностике рака пищевода // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2006. Т. 16, № 2. С. 63–78.
37. Levine M.S., Chu P., Furth E.E. et al. Carcinima of the esophagus and esophagogastric junction: sensitivity of radiographic diagnosis // AJR Am. J. Roentgenol. 1997. Vol. 168, N 6. P. 1423–1426.
38. Bhutani M.S., Barde C.J., Markert R.J., Gopalswamy N. Length of esophageal cancer and degree of luminal stenosis during upper endoscopy predict T stage by endoscopic ultrasound // Endoscopy. 2002. Vol. 34, N 6. P. 461–463.
39. Rice T.W. Diagnosis and staging of esophageal cancer. In: Pearson’s thoracic and esophageal surgery. Philadelphia : Churchill Livingstone/Elsevier, 2008. P. 454–463.
40. Napier Kyle J., Scheerer M., Misra Subhasis. Esophageal cancer: A review of epidemiology, pathogenesis, staging workup and treatment modalities // World J. Gastrointest. Oncol. 2014. Vol. 6, N 5. P. 112–120.
41. van Vliet E.P., Heijenbrok-Kal M.H., Hunink M.G. et al. Staging investigation for oesophageal cancer: a meta-analysis // Br. J. Cancer. 2008. Vol. 98, N 3. P. 547–557.
42. Schreurs L.M., Janssens A.C., Groen H. et al. Value of EUS in determining curative resectability in reference to CT and FDG-PET: the optimal sequence in preoperative staging of esophageal cancer? // Ann. Surg. Oncol. 2016. Vol. 23. P. 1021–1026.
43. Meyers B.F., Downey R.J., Decker P.A. et al, and the American College of Surgeons Oncology Group Z0060. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial // J. Thorac. Cardiovasc. Surg. 2007. Vol. 133. P. 738–745.
44. van Westreenen H.L., Heeren P.A., va Dullemen H.M. et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of oesophageal cancer prevents unnecessary surgical explorations // Journal Gastrointestinal Surgery. 2005. Vol. 9, N 1. P. 54–61.
45. Mizowaki T., Nishimura Y., Shimada Y. et al Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: evaluation by computed tomography and magnetic resonance imaging // Int. J. Radiat. Oncol. Biol. Phys. 1996. Vol. 36. P. 1091–1098.
46. Nakashima A., Nakashima K., Seto H. et al. Thoracic esophageal carcinoma: evaluation in the sagittal section with magnetic resonance imaging // Abdom. Imaging. 1997. Vol. 22. P. 20–23.
47. Sakurada A., Takahara T., Kwee T.C. Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer // Eur. Radiol. 2009. Vol. 19. P. 1461–1469.
48. Riddell A.M., Allum W.H., Thompson J.N. et al. The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathological correlation // Eur. Radiol. 2007. Vol. 17. P. 391–399.
49. Nishimura H., Tanigawa N., Hiramatsu M. et al. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide // J. Am. Coll. Surg. 2006. Vol. 202. P. 604–611.
50. Chang E.Y., Li X., Jerosch-Herold M. et al. The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging // J. Gastrointest. Surg. 2008. Vol. 12. P. 166–175.
51. Oberholzer K., Pohlmann A., Schreiber W. et al. Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience // J. Magn. Reson. Imaging. 2008. Vol. 27. P. 1296–1301.
52. Aoyagi T., Shuto K., Okazumi S. et al Evaluation of the clinical staging of esophageal cancer by using diffusion-weighted imaging // Exp. Ther. Med. 2010. N 1. P. 847–851.
53. Alper F., Turkyilmaz A., Kurtcan S. et al. Effectiveness of the STIR turbo spin-echo sequence MR imaging in evaluation of lymphadenopathy in esophageal cancer // Eur. J. Radiol. 2011. Vol. 80. P. 625–628.
54. Хайруддинов Р.В. Современные принципы диагностики и хирургического лечения рака пищевода // Вестник хирургии И.И.Грекова. 2006. Т. 165, № 3. С. 48–51.
55. Krasna M.J., Jiao X., Mao Y.S. et al. Thoracoscopy/laparoscopy in the staging of esophageal cancer // Surg. Laparosc. Endosc. Percutan. Tech. 2002. Vol. 12. P. 213–218.
56. Pennathur А., Gibson M.K., Jobe B.A., Luketich J.D. Oesophageal carcinoma // Lancet. 2013. Vol. 381. P. 400–412.
57. Василевский Д.И., Камалов Е.Н., Дворецкий С.Ю. и др. Частота выявления цилиндроклеточной метаплазии и аденокарциномы пищевода у жителей Ленинградской области (по данным эзофагогастродуоденоскопии) // Ученые записки СПбГМУ им. акад. И.П. Павлова. 2014. Т. 21. № 4. С. 44–47.
58. Ивашикин Ю.М., Комаров И.В., Дворецкий С.Ю. и др. Способ диагностики распространения неопластического процесса пищевода: пат. 2566185 Рос. Федерация; опубл. 24.09.2015.
59. Дворецкий С.Ю., Комаров И.В., Чистяков И.В. и др. Диагностика и лечение рака пищевода: учебно-методическое пособие для клинических ординаторов, аспирантов, торакальных хирургов, онкологов. Санкт-Петербург : РИЦ ПСПбГМУ, 2019. 36 с.